PERSPECTA

News from every angle

← Back to headlines

INVO BioScience Beats EPS, Cue Biopharma Misses EPS in Latest Earnings

INVO BioScience reported GAAP EPS of $0.35, significantly beating estimates, though revenue missed expectations. Meanwhile, Cue Biopharma's GAAP EPS of -$24.14 missed by a large margin, despite its revenue beating forecasts.

17 Aug, 17:11 — 17 Aug, 17:11
PostShare

Sources

Showing 1 of 1 sources
seeking-alphaMixed11d ago

Prairie Operating Co. GAAP EPS of $0.23 beats by $0.11, revenue of $98.86M misses by $25.14M

Read full article →

Related Stories

BYD Reports First Quarterly Profit Rise in Over a Year on Export Surge

29m ago

Fed Chair Warsh Signals Hawkish Stance on Inflation at Jackson Hole

30m ago

US-Mexico Trade Talks Stall Over Dispute on Cheese Names

57m ago

Walmart Reaches Settlement With U.S. Government Over Opioid Crisis

1h ago